Bioident wins illustrious 2007 Wall Street Journal Technology Innovation Awards

Printed semiconductor-based technology named co-winner for Lab-on-a-Chip with real-time results

04-Oct-2007

Bioident Technologies Inc. announced that the company is a co-winner in the semiconductor category for the seventh annual Wall Street Journal contest for Technology Innovation. Bioident was awarded for the development of its PhotonicLab Platform(TM), which enables rapid in-vitro diagnostics, chemical and biological threat detection, and environmental testing without the need for off-site lab analysis.

Utilizing the latest breakthroughs in science and nanotechnology, the Bioident PhotonicLab Platform is used to produce the world's first disposable photonic lab-on-achip solution for next-generation mobile analytics applications, such as water and food analysis, chemical and biological agent detection, and point-of-care diagnostics. employs a process developed by its parent company, Austria's Nanoident Technologies AG, for using an inkjet printer to print electronic circuits on a variety of surfaces, such as plastic foil or glass; the technology makes it possible to apply photosensitive semiconductors directly onto a lab-on-a-chip. The Platform eliminates the need for complex and expensive readout systems and delivers unprecedented mobility and sensitivity based on existing biological and chemical assays.

Other news from the department business & finance

Most read news

More news from our other portals

Under the magnifying glass: The world of microscopy

See the theme worlds for related content

Topic world Diagnostics

Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.

View topic world
Topic world Diagnostics

Topic world Diagnostics

Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.